Robert Dallara, MD
Pain Medicine · Uniontown, OHNPI 1477829356
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (33.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Boston Scientific at 40.9% of the total. Reporting peaked in 2021 at $9,198 and has fallen 91.9% since, to $748 in 2025. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 346 payments — averaging $94.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- Medtronic$9K
- Abbott$4K
- Saluda Medical Americas, Inc.$2K
- Nevro Corp.$1K
- Stryker$1K
- plus $2K from 14 others
What the payments were for
- Consulting fees$7,73824%
- Speaking & faculty fees$2,7688%
- Travel & lodging$11,03834%
- Food & beverage$10,99934%
- Education$1090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 71 | $13,367 |
| Medtronic(2 entities) | 50 | $8,713 |
| Abbott | 74 | $4,157 |
| Saluda Medical Americas, Inc. | 16 | $2,198 |
| Nevro Corp. | 28 | $1,396 |
| Stryker | 13 | $1,138 |
| Collegium Pharmaceutical, Inc. | 47 | $638 |
| Biodelivery Sciences International, Inc. | 25 | $277 |
| SPR Therapeutics, Inc | 2 | $144 |
| Nalu Medical, Inc. | 2 | $137 |
| Averitas Pharma Inc. | 4 | $125 |
| Spinal Simplicity, LLC | 1 | $109 |
| Relievant Medsystems, Inc. | 2 | $58 |
| Foundation Fusion Solutions, LLC | 2 | $42 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Protega Pharmaceutials Inc | 2 | $32 |
| Painteq LLC | 2 | $31 |
| IBSA Pharma Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$5,400
- INTELLIS ADAPTIVESTIM$4,497
- GENERAL - THERAPIES$2,952
- INTELLIS$1,888
- PROCLAIM$1,676
- WaveWriter Alpha Prime 16$1,310
- Evoke SCS$1,205
- SPINEJACK$769
- SYNCHROMED$661
- Omnia$505
- Proclaim IPG$500
- Evoke$454
- Proclaim Family of SCS IPGs$332
- Intracept$328
- ETERNA$230
- PRECISION$223
- Nalu Neurostimulation System$113
- Senza$111
- HA MINUTEMAN G3-R$109
How this compares
$32,652 in reported general payments places this provider in the 95th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 76 | $68,965 |
| NucyntaTapentadol Hcl | 21 | $29,616 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 695 | $20,145 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 744 | $17,460 |
| Nucynta ErTapentadol Hcl | 12 | $16,812 |
| OxycontinOxycodone Hcl | 30 | $15,997 |
| Buprenorphine | 51 | $14,915 |
| BelbucaBuprenorphine Hcl | 12 | $11,410 |
| Oxycodone Hcl | 414 | $9,596 |
| Pregabalin | 238 | $8,752 |
| LyricaPregabalin | 13 | $7,514 |
| MovantikNaloxegol Oxalate | 15 | $7,251 |
| Fentanyl | 59 | $6,643 |
| Gabapentin | 448 | $6,387 |
| Hydromorphone Hcl | 240 | $4,904 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er, Belbuca | $638 | $126,804121 claims |
| Hikma Pharmaceuticals USABuprenorphine | $35 | $14,91551 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Uniontown
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.